Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
abatacept (orencia) (2 trials)
golimumab (simponi) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
insulin human (humulin) (1 trial)
methyldopa (aldomet) (1 trial)
rituximab (rituxan) (2 trials)
teplizumab (Tzield) (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Glucose Intolerance (Phase 2)
Trials (8 total)
Trial APIs (7 total)